Ubs Group Ag Amicus Therapeutics, Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 563,972 shares of FOLD stock, worth $5.45 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

563,972

Previous 486,767 15.86%

Holding current value

$5.45 Million

Previous $4.83 Million 24.75%

% of portfolio

0.0%

Previous 0.0%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$9.55 - $12.09 $737,307 - $933,408	77,205 Added 15.86%	563,972 $6.02 Million
Q2 2024 Aug 13, 2024	SELL	$9.04 - $11.75 $3.72 Million - $4.83 Million	-411,129 Reduced 45.79%	486,767 $4.83 Million
Q1 2024 May 13, 2024	BUY	$11.43 - $14.24 $836,538 - $1.04 Million	73,188 Added 8.87%	897,896 $10.6 Million
Q4 2023 Feb 09, 2024	BUY	$9.97 - $14.52 $3.02 Million - $4.4 Million	303,038 Added 58.09%	824,708 $11.7 Million
Q3 2023 Nov 09, 2023	BUY	$11.78 - $13.86 $1.43 Million - $1.68 Million	121,102 Added 30.23%	521,670 $6.34 Million
Q2 2023 Aug 11, 2023	BUY	$10.72 - $13.3 $1.4 Million - $1.73 Million	130,321 Added 48.22%	400,568 $5.03 Million
Q1 2023 May 12, 2023	SELL	$10.91 - $13.54 $3.34 Million - $4.14 Million	-306,104 Reduced 53.11%	270,247 $3 Million
Q4 2022 Feb 08, 2023	BUY	$9.89 - $12.7 $3.88 Million - $4.99 Million	392,760 Added 213.93%	576,351 $7.04 Million
Q3 2022 Nov 10, 2022	SELL	$9.82 - $12.75 $949,976 - $1.23 Million	-96,739 Reduced 34.51%	183,591 $1.92 Million
Q2 2022 Aug 10, 2022	SELL	$6.23 - $11.12 $1.45 Million - $2.58 Million	-232,112 Reduced 45.3%	280,330 $3.01 Million
Q1 2022 May 16, 2022	BUY	$7.89 - $12.48 $288,553 - $456,418	36,572 Added 7.69%	512,442 $4.85 Million
Q4 2021 Feb 14, 2022	BUY	$9.82 - $12.44 $1.45 Million - $1.84 Million	148,024 Added 45.15%	475,870 $5.5 Million
Q3 2021 Nov 15, 2021	BUY	$8.74 - $11.84 $1.61 Million - $2.19 Million	184,656 Added 128.96%	327,846 $3.13 Million
Q2 2021 Aug 13, 2021	SELL	$8.71 - $10.72 $1.61 Million - $1.99 Million	-185,310 Reduced 56.41%	143,190 $1.38 Million
Q1 2021 May 12, 2021	BUY	$9.2 - $23.86 $566,738 - $1.47 Million	61,602 Added 23.08%	328,500 $3.25 Million
Q4 2020 Feb 11, 2021	BUY	$13.47 - $24.89 $1.2 Million - $2.23 Million	89,438 Added 50.4%	266,898 $6.16 Million
Q3 2020 Nov 12, 2020	SELL	$12.89 - $15.89 $68,716 - $84,709	-5,331 Reduced 2.92%	177,460 $2.51 Million
Q2 2020 Jul 31, 2020	BUY	$8.86 - $15.69 $73,777 - $130,650	8,327 Added 4.77%	182,791 $2.76 Million
Q1 2020 May 01, 2020	SELL	$6.63 - $11.16 $828,577 - $1.39 Million	-124,974 Reduced 41.74%	174,464 $1.61 Million
Q4 2019 Feb 14, 2020	SELL	$7.48 - $10.75 $4.16 Million - $5.98 Million	-556,404 Reduced 65.01%	299,438 $2.92 Million
Q3 2019 Nov 14, 2019	BUY	$8.02 - $13.25 $4.5 Million - $7.44 Million	561,151 Added 190.42%	855,842 $6.86 Million
Q2 2019 Aug 14, 2019	BUY	$10.96 - $14.4 $1.51 Million - $1.98 Million	137,703 Added 87.72%	294,691 $3.68 Million
Q1 2019 May 14, 2019	SELL	$10.04 - $13.92 $6.99 Million - $9.69 Million	-696,041 Reduced 81.6%	156,988 $2.14 Million
Q4 2018 Feb 14, 2019	BUY	$8.38 - $13.44 $4.85 Million - $7.78 Million	579,214 Added 211.53%	853,029 $8.17 Million
Q3 2018 Nov 14, 2018	BUY	$11.6 - $16.54 $3,990 - $5,689	344 Added 0.13%	273,815 $3.31 Million
Q2 2018 Aug 14, 2018	SELL	$13.13 - $17.09 $3.63 Million - $4.72 Million	-276,268 Reduced 50.25%	273,471 $4.27 Million
Q1 2018 May 15, 2018	BUY	$13.76 - $17.12 $4.36 Million - $5.42 Million	316,537 Added 135.74%	549,739 $8.27 Million
Q4 2017 Feb 14, 2018	SELL	$12.51 - $16.24 $880,966 - $1.14 Million	-70,421 Reduced 23.19%	233,202 $3.36 Million
Q3 2017 Nov 14, 2017	BUY	$11.74 - $15.78 $2.13 Million - $2.87 Million	181,771 Added 149.17%	303,623 $4.58 Million
Q2 2017 Aug 14, 2017	BUY	N/A	17,461 Added 16.73%	121,852 $1.23 Million
Q1 2017 Nov 14, 2017	BUY	N/A	104,391	104,391 $744,000

Others Institutions Holding FOLD

# of Institutions

313

Shares Held

314M

Call Options Held

516K

Put Options Held

833K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.71B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account